Apable, Joaressa Fe S.

HRN: 22-25-99  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2022
CEFUROXIME 1.5GM (VIAL)
11/30/2022
12/07/2022
IV
1.5g
Q8
Open Fracture
Waiting Final Action 
12/05/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/05/2022
12/11/2022
IVT
600mg Ivt
Q6 X 7 Days
Fracture Prophylaxis, Skin Abrasions
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: